Drugs / Nicotine Replacement Therapy (NRT)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT03315910 | Oct 2017 → Oct 2026 expected | — | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT01800019 Comparator | Jan 2014 → Dec 2017 | HIV infectious disease | Ottawa Hospital Research Institute | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nicotine Replacement Therapy (NRT) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01800019 ↗ |